The global non-animal alternative testing market size was US$ 9.8 billion in 2021. The global non-animal alternative testing market size is estimated to reach US$ 30.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.5% during the forecast period from 2022 to 2030.
Sales of non-animal alternative testing products and services, which do not use animals in testing to set safety needs for products like cosmetics and pharmaceuticals, are included in the non-animal alternatives testing market. Drug and cosmetic items are tested utilizing non-animal procedures in the non-animal alternative testing sector. Some processes and methodologies used as an option for animal testing contain organs-on-chip, in-vitro testing, and in-silico testing.

Factors Influencing Market Growth

• Support from government and non-governmental organizations drives the overall market expansion. 
• The legal demands in some countries for animal testing hinder the overall market growth.
• OOCs are tiny organs and tissues developed in a dish that allows researchers to simulate human physiology and illness driving the overall market expansion.

Effect of the COVID-19 Pandemic

COVID-19 had a positive impact on the overall market growth. The pharmaceutical sector had seen significant growth in the need for medications during the pandemic as individuals' awareness concerning their health and well-being improved. Also, during pre-clinical drug testing, many drug developers avoided performing in wet laboratories and coming into direct touch with animals or humans. Thus, driving the overall market growth.

Regional Analysis

North America had the highest global market in 2020. Major non-animal alternative testing organizations like Abbott Laboratories are current in the region, which is considered to be a primary contributor to the growth. The market for non-animal alternative testing is also expected to develop owing to the aging population and the incidence of chronic diseases among the population of the region.

Leading Competitors
The prominent players in the global non-animal alternative testing market are:
• TissUse GmbH
• Hurel Corporation
• Abbott
• Bio-Rad Laboratories
• VITROCELL Systems
• Evotec SE
• MB Research Laboratories
• Emulate
• TARA Biosystems
• Biovit
• Others
Segmentation Analysis
The global non-animal alternative testing market segmentation focuses on Technology, Method, End User, and Region.
Segmentation on the basis of Technology
• Cell Culture
• High Throughput
• Molecular Imaging
• OMIC Technology
Segmentation on the basis of Method
• Cellular Assay
• Biochemical Assay
• In-silico
• Ex-vivo

Segmentation on the basis of End Use
• Pharmaceutical Industry
• Cosmetics & Household Products
• Diagnostics
• Chemicals Industry
• Food Industry

Segmentation on the basis of Region
• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America